---
category: news
title: "Bio­Marin taps AI up­start Deep Ge­nomics for dis­cov­ery pact; Prax­is says it has a path to lift­ing clin­i­cal hold"
excerpt: "Years after double FDA/EMA rejections left BioMarin’s oligonucleotide for Duchenne muscular dystrophy languishing on the shelf, the company is going back to the drawing board for new oligonucleotide drug candidates — with a healthy dose of artificial intelligence."
publishedDateTime: 2020-11-17T15:30:00Z
originalUrl: "https://endpts.com/biomarin-taps-ai-upstart-deep-genomics-for-discovery-pact-praxis-says-it-has-a-path-to-lifting-clinical-hold/"
webUrl: "https://endpts.com/biomarin-taps-ai-upstart-deep-genomics-for-discovery-pact-praxis-says-it-has-a-path-to-lifting-clinical-hold/"
type: article
quality: 13
heat: 13
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - AI

images:
  - url: "https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg"
    width: 2048
    height: 1024
    isCached: true

secured: "rVXyR1c129yqNZwJnGznE+NmoN2Jg9MvfqgaXJYlcHk8j/kRrxVz/UDIh8WemD2WFpL1X6hRb9gkPvSt1FOFF+7YFaKhEbyz4cX+gSxOSCZ+O1i3JrcDRpiieGJwp7uly55CiaQQvizAwha7fjNruiGWN9QSNNMgN5fb1U2TP4vKEUSJOwIKenS0jjXu3nFrF/+Yvj6NnAYlH7OB2V09QlU7JYZM9s6/R/RS35Cu3UWOmYj3AnPKuEUYLxkhHcvUF4PEm67Sjy4tVl8j7PIhNOf1Wc0y7Y4qhEzGe1npQLoxIhR0j5OGMbRBoJlc2fD8ZzWvzih/Naw/oqnTKpmdbUObvTyuOjYPCurxIuqxiCY=;ODjYgWPkMF5jLFIiZpmatw=="
---

